Replies to post #77386 on Anavex Life Sciences Corp (AVXL)

[bas2020]

Nice post, seventhwave. Your thoughts resonate. I'd like it very much if Anavex would report the 36-wk update, suggesting monotherapy efficacy and that they moved more patients to monotherapy for the balance of the trial. Next readout at 48 weeks and Ariana's KEM technology to analyze the results.

It could happen...